Caroline Goddeeris

About

Caroline Goddeeris holds a PhD in Pharmaceutical Sciences followed by an MBA and master in corporate finance, both from Vlerick Business School. She started her career at UCB taking on various roles in strategy (portfolio management, business development, new product planning) and operations (marketing and sales). Prior to joining Fund+, Caroline was a principal at Gimv with board responsibilities at Complix and Multiplicom (sold to Agilent). Caroline currently serves on the board of Confo Therapeutics and is responsible for the follow up of our Tubulis investment.

Source (opens in a new tab)